141 related articles for article (PubMed ID: 20502274)
1. A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration.
Togashi Y; Masago K; Mishima M; Fukudo M; Inui K
J Thorac Oncol; 2010 Jun; 5(6):924-5. PubMed ID: 20502274
[No Abstract] [Full Text] [Related]
2. Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis.
Um SJ; Lee SK; Yang DK; Son C; Roh MS; Kim KN; Lee KN; Choi PJ
Clin Respir J; 2009 Jul; 3(3):181-4. PubMed ID: 20298401
[TBL] [Abstract][Full Text] [Related]
3. Temporal dependence of the effect of radiation on erlotinib-induced skin rash.
Lacouture ME; Hwang C; Marymont MH; Patel J
J Clin Oncol; 2007 May; 25(15):2140; author reply 2141. PubMed ID: 17513824
[No Abstract] [Full Text] [Related]
4. Exacerbation of radiation fibrosis with erlotinib: another pattern of radiation recall phenomenon.
Arakawa H; Johkoh T; Sakai F; Kusumoto M; Hataji O; Taguchi O
Jpn J Radiol; 2011 Oct; 29(8):587-9. PubMed ID: 21928002
[TBL] [Abstract][Full Text] [Related]
5. Palmar bullous blistering induced by erlotinib.
Berg A; Brustugun OT; Lund-Iversen M; Helland Å
J Thorac Oncol; 2011 May; 6(5):954. PubMed ID: 21623268
[No Abstract] [Full Text] [Related]
6. Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient.
Tsubata Y; Hamada A; Sutani A; Isobe T
J Cancer Res Ther; 2012; 8(1):154-6. PubMed ID: 22531540
[TBL] [Abstract][Full Text] [Related]
7. Erlotinib-associated alopecia in a lung cancer patient.
Costa DB; Kobayashi S; Schumer ST
J Thorac Oncol; 2007 Dec; 2(12):1136-8. PubMed ID: 18090591
[No Abstract] [Full Text] [Related]
8. An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer.
Toh CK; Lee P; Chowbay B; Goh JW; Mancer K; Tan PH
Acta Oncol; 2007; 46(2):256-8. PubMed ID: 17453379
[No Abstract] [Full Text] [Related]
9. Pulmonary toxicity associated with erlotinib.
Liu V; White DA; Zakowski MF; Travis W; Kris MG; Ginsberg MS; Miller VA; Azzoli CG
Chest; 2007 Sep; 132(3):1042-4. PubMed ID: 17873198
[TBL] [Abstract][Full Text] [Related]
10. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.
Nanda A; Dias-Santagata DC; Stubbs H; O'Hara CJ; Zaner KS; Lynch TJ; Willers H
Clin Lung Cancer; 2008 Sep; 9(5):285-7. PubMed ID: 18824451
[TBL] [Abstract][Full Text] [Related]
11. Sparing of previously irradiated skin from erlotinib-induced acneiform rash.
Yalçin S; Dizdar O; Yalçin B; Gököz O
J Am Acad Dermatol; 2008 Jan; 58(1):178-9. PubMed ID: 18158935
[No Abstract] [Full Text] [Related]
12. Erlotinib or gefitinib for non-small-cell lung cancer.
Yusuf SW; Kim P; Durand JB
N Engl J Med; 2011 Jun; 364(24):2367; author reply 2368. PubMed ID: 21675910
[No Abstract] [Full Text] [Related]
13. Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin.
Acharya J; Lyon C; Bottomley DM
J Am Acad Dermatol; 2009 Jan; 60(1):154-7. PubMed ID: 19103369
[TBL] [Abstract][Full Text] [Related]
14. Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report.
Hsieh CH; Chang HT; Lin SC; Chen YJ; Wang LY; Hsieh YP; Chen CA; Chong NS; Lin SL; Chen CY; Shueng PW
BMC Cancer; 2010 Dec; 10():696. PubMed ID: 21194444
[TBL] [Abstract][Full Text] [Related]
15. Radiation pneumonitis in patients with non--small-cell lung cancer treated with erlotinib concurrent with thoracic radiotherapy.
Zhuang H; Yuan Z; Chang JY; Wang J; Pang Q; Zhao L; Wang P
J Thorac Oncol; 2014 Jun; 9(6):882-5. PubMed ID: 24828665
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects.
Gerber PA; Enderlein E; Homey B; Muller A; Boelke E; Budach W
J Clin Oncol; 2007 Oct; 25(29):4697-8; author reply 4698-9. PubMed ID: 17925571
[No Abstract] [Full Text] [Related]
17. Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).
Cho YS; Park J; Kim JI; Nam KH; Yun SK; Kim HU
Int J Dermatol; 2014 Mar; 53(3):e190-2. PubMed ID: 23675736
[No Abstract] [Full Text] [Related]
18. Erlotinib-associated acute pneumonitis: report of two cases.
Vahid B; Esmaili A
Can Respir J; 2007 Apr; 14(3):167-70. PubMed ID: 17464382
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure.
Gridelli C; Maione P; Galetta D; Rossi A
J Thorac Oncol; 2007 Jan; 2(1):96-8. PubMed ID: 17410020
[No Abstract] [Full Text] [Related]
20. Fatal interstitial lung disease after erlotinib for non-small cell lung cancer.
Lind JS; Smit EF; Grünberg K; Senan S; Lagerwaard FJ
J Thorac Oncol; 2008 Sep; 3(9):1050-3. PubMed ID: 18758310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]